Dolby Laboratories (NYSE:DLB – Get Free Report) shares gapped up before the market opened on Friday following a better than expected earnings announcement. The stock had previously closed at $51.78, but opened at $56.55. Dolby Laboratories shares last traded at $56.9480, with a volume of 89,117 shares traded.
The electronics maker reported $0.69 earnings per share for the quarter, topping the consensus estimate of $0.67 by $0.02. The business had revenue of $305.00 million for the quarter, compared to analysts’ expectations of $311.96 million. Dolby Laboratories had a return on equity of 11.47% and a net margin of 17.85%.The business’s revenue for the quarter was down 3.3% compared to the same quarter last year. During the same period in the previous year, the firm posted $0.78 EPS. Dolby Laboratories has set its FY 2026 guidance at 4.250-4.400 EPS and its Q4 2026 guidance at 1.130-1.280 EPS.
Dolby Laboratories Dividend Announcement
The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, August 19th. Shareholders of record on Tuesday, August 11th will be paid a dividend of $0.36 per share. The ex-dividend date of this dividend is Tuesday, August 11th. This represents a $1.44 dividend on an annualized basis and a yield of 2.5%. Dolby Laboratories’s payout ratio is 56.92%.
Key Dolby Laboratories News
Here are the key news stories impacting Dolby Laboratories this week:
- Positive Sentiment: Q3 adjusted earnings beat expectations: Dolby reported adjusted EPS of $0.69, above the $0.67 consensus estimate, helped by lower operating expenses. Dolby’s Q3 Earnings Beat Estimates on Lower Operating Expenses
- Positive Sentiment: Optimistic Q4 and full-year outlook: Q4 revenue guidance of $362 million-$392 million exceeded the $351.1 million consensus, while full-year adjusted EPS guidance of $4.25-$4.40 was above the $4.10 estimate. Management cited video licensing, automotive applications and new device categories as growth drivers. Dolby Laboratories Reports Third Quarter 2026 Financial Results
- Positive Sentiment: Capital returns support the stock: Dolby authorized a $350 million share-repurchase program, covering up to 7% of outstanding shares, and declared a quarterly dividend of $0.36 per share. Rosenblatt Securities also reaffirmed its “buy” rating with an $85 price target. Rosenblatt Reaffirms Buy Rating
- Neutral Sentiment: Cash generation remained strong: Operating cash flow increased to $167.5 million, and Dolby ended the quarter with $669.4 million in cash and equivalents, providing flexibility for buybacks, dividends and investment.
- Negative Sentiment: Revenue and profitability weakened: Q3 revenue fell 3.3% year over year to $305 million and missed estimates near $312 million. Adjusted EPS declined from $0.78 a year earlier, while reported diluted EPS was $0.30 and operating profit fell to $34.3 million. Dolby Laboratories Fiscal Q3 Adjusted Earnings, Revenue Fall
- Negative Sentiment: Insider selling may weigh on sentiment: Recent filings showed multiple executives selling shares, with no reported insider purchases during the period cited.
Analyst Ratings Changes
Several research firms have recently commented on DLB. Wall Street Zen upgraded Dolby Laboratories from a “hold” rating to a “buy” rating in a report on Saturday, May 30th. Barrington Research reissued an “outperform” rating and issued a $90.00 price objective on shares of Dolby Laboratories in a report on Monday, June 15th. Rosenblatt Securities restated a “buy” rating and set a $85.00 price objective on shares of Dolby Laboratories in a research report on Friday. Finally, Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Dolby Laboratories in a research note on Wednesday, June 24th. Three research analysts have rated the stock with a Buy rating and two have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $90.75.
Get Our Latest Analysis on Dolby Laboratories
Insiders Place Their Bets
In other Dolby Laboratories news, SVP John D. Couling sold 7,667 shares of Dolby Laboratories stock in a transaction on Wednesday, July 1st. The stock was sold at an average price of $53.20, for a total value of $407,884.40. Following the sale, the senior vice president owned 118,727 shares in the company, valued at $6,316,276.40. The trade was a 6.07% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, CMO Todd Pendleton sold 11,876 shares of the company’s stock in a transaction on Friday, May 22nd. The shares were sold at an average price of $54.55, for a total value of $647,835.80. Following the completion of the transaction, the chief marketing officer directly owned 41,480 shares in the company, valued at approximately $2,262,734. This trade represents a 22.26% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last ninety days, insiders have sold 47,458 shares of company stock valued at $2,639,537. 37.93% of the stock is currently owned by insiders.
Institutional Trading of Dolby Laboratories
A number of hedge funds and other institutional investors have recently modified their holdings of DLB. Fifth Third Bancorp raised its holdings in Dolby Laboratories by 34.7% in the 4th quarter. Fifth Third Bancorp now owns 746 shares of the electronics maker’s stock valued at $48,000 after buying an additional 192 shares during the period. Aquatic Capital Management LLC purchased a new position in Dolby Laboratories during the third quarter worth about $56,000. iSAM Funds UK Ltd purchased a new position in Dolby Laboratories during the third quarter worth about $68,000. Quarry LP increased its position in shares of Dolby Laboratories by 1,486.7% during the fourth quarter. Quarry LP now owns 1,190 shares of the electronics maker’s stock valued at $76,000 after acquiring an additional 1,115 shares during the last quarter. Finally, Farther Finance Advisors LLC increased its position in shares of Dolby Laboratories by 48.4% during the fourth quarter. Farther Finance Advisors LLC now owns 1,232 shares of the electronics maker’s stock valued at $79,000 after acquiring an additional 402 shares during the last quarter. 58.56% of the stock is owned by institutional investors and hedge funds.
Dolby Laboratories Stock Performance
The business’s 50 day moving average price is $52.21 and its 200-day moving average price is $58.58. The firm has a market capitalization of $5.48 billion, a PE ratio of 22.85 and a beta of 0.81.
About Dolby Laboratories
Dolby Laboratories, Inc is a global leader in audio and imaging technologies, specializing in the development, licensing and deployment of solutions that enhance entertainment and communications experiences. The company’s core business revolves around creating advanced audio codecs, noise reduction systems and spatial sound technologies for a wide range of applications, including cinema, broadcast, gaming, streaming and personal devices. Dolby’s licensing model enables consumer electronics manufacturers, content creators and service providers to integrate its technologies into products such as televisions, smartphones, home theater systems and set-top boxes.
Among its flagship innovations are Dolby Atmos, an immersive audio format that delivers three-dimensional soundscapes for theaters and home systems; Dolby Digital and Dolby Digital Plus, widely adopted audio compression formats for broadcast and streaming; and Dolby Vision, a high-dynamic-range imaging technology that expands color, contrast and brightness in displays.
Featured Stories
- Five stocks we like better than Dolby Laboratories
- Generac’s AI Power Story Is Becoming Bigger Than the Weather
- Everyone’s Focused on China—But That’s Not ASML’s Biggest Risk
- Chipotle Mexican Grill Stock Rallies as Q2 Results Top Fears, Guidance Rises
- L3Harris’ Record Backlog Makes Its Stock Sell-Off Look Overdone
Receive News & Ratings for Dolby Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dolby Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.
